HGBL · Heritage Global Inc. · Insider Trading
One customer — 78% of receivables (March 31, 2026)
“As of March 31, 2026, we held a gross balance of investments in notes receivable of $27.3 million, recorded in both notes receivable and equity method investments, and consisting of one borrower’s note balance of approximately $21.4 million, representing 78% of our total gross notes receivable balance as of March 31, 2026, as compared to 76% as of December 31, 2025.”
One customer — 76% of receivables (December 31, 2025)
“As of March 31, 2026, we held a gross balance of investments in notes receivable of $27.3 million, recorded in both notes receivable and equity method investments, and consisting of one borrower’s note balance of approximately $21.4 million, representing 78% of our total gross notes receivable balance as of March 31, 2026, as compared to 76% as of December 31, 2025.”
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score Cluster buy
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-10-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
2,500 |
| 2026-09-25 | Burnham William L |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The reported shares were purchased by Inductive Capital LP in a privately negotiated transaction from Ross Dove, Chief Executive Officer and a director of the Issuer, at a price of $1.33 per share, pursuant to a Common Stock Purchase Agreement dated 9-25-26. The transaction was not effected on a securities exchange or through a broker. Transfer of the shares into the name of Inductive Capital LP is expected to be completed following the transaction date through the Issuer's transfer agent. The $1.33 per-share price equaled the Nasdaq closing price on 9/24/2026. The shares are held directly by Inductive Capital LP. Inductive Holdings, LLC is the general partner of Inductive Capital LP, and the reporting person is the managing member of Inductive Holdings, LLC. The reporting person may therefore be deemed to beneficially own the shares held by Inductive Capital LP. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
Common Stock
(I)
|
300,000 |
| 2026-09-25 | DOVE ROSS |
Director, CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported shares were sold in a privately negotiated transaction to Inductive Capital LP, an entity controlled by William L. Burnham, a director of the Issuer, at a price of $1.33 per share, pursuant to a Common Stock Purchase Agreement dated 9-25-26. The transaction was not effected on a securities exchange or through a broker. Transfer of the shares into the name of Inductive Capital LP is expected to be completed following the transaction date through the Issuer's transfer agent. The $1.33 per-share price equaled the Nasdaq closing price on 9/24/2026. |
Common Stock
|
300,000 |
| 2026-09-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
2,500 |
| 2026-08-20 | COBB BRIAN J. |
CFO |
Buy↑
|
Common Stock
|
20,000 |
| 2026-08-17 | Dove Nicholas Kirk |
President, Industrial Assets |
Buy↑
|
Common Stock
|
60,000 |
| 2026-08-17 | Hounsell Bruce Kenneth |
President, Heritage DebtX LLC |
Buy↑
|
Common Stock
|
10,000 |
| 2026-05-21 | Dove Nicholas Kirk |
President, Industrial Assets |
Buy↑
|
Common Stock
|
26,000 |
| 2026-05-14 | Ludwig Thomas Van |
President, NLEX |
Convert↓
Filing footnotes — Options to purchase common stock (Direct)
Options were granted 6/1/2019 and vested 25% annually beginning on the first anniversary of the grant date. |
Options to purchase common stock
|
31,875 |
| 2026-05-14 | Ludwig Thomas Van |
President, NLEX |
Tax↑
|
Common Stock
|
23,919 |
| 2026-05-14 | Ludwig Thomas Van |
President, NLEX |
Convert↑
|
Common Stock
|
31,875 |
| 2026-05-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.31 to $1.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2026-04-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.31 to $1.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2026-03-05 | Hexner Michael |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-05 | Burnham William L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-05 | Sharpe Kelly S |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-05 | SHIMER SAMUEL L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-05 | Sinsley Barbara A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 5, 2026; 25% vesting on September 5, 2026; 25% vesting on December 5, 2026; and 25% vesting on March 5, 2027 |
Common Stock
|
20,000 |
| 2026-03-02 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2026-02-02 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.35 to $1.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2026-01-02 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.22 to $1.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2025-12-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.30 to $1.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2025-11-03 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.41 to $1.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
3,734 |
| 2025-10-01 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
7,468 |
| 2025-03-25 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by Heritage Global Inc. to satisfy tax withholding on restricted stock |
Common Stock
|
4,727 |
| 2025-03-25 | DOVE ROSS |
Director, CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by Heritage Global Inc. to satisfy tax withholding on restricted stock |
Common Stock
|
25,094 |
| 2025-03-25 | COBB BRIAN J. |
CFO |
Tax↓
Filing footnotes — Common Stock (Direct)
Shares withheld by Heritage Global Inc. to satisfy tax withholding on restricted stock |
Common Stock
|
6,408 |
| 2025-03-11 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.91 to $2.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
7,000 |
| 2025-03-06 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.03 to $2.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-03-06 | Burnham William L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-06 | DOVE ROSS |
Director, CEO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest in full on March 6, 2026. |
Common Stock
|
44,355 |
| 2025-03-06 | SHIMER SAMUEL L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-06 | COBB BRIAN J. |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest in full on March 6, 2026. |
Common Stock
|
11,848 |
| 2025-03-06 | Sklar James Edward |
EVP, Gen Counsel & Secretary |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest in full on March 6, 2026. |
Common Stock
|
11,848 |
| 2025-03-06 | Hexner Michael |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-06 | Sharpe Kelly S |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-06 | Sinsley Barbara A |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and will vest quarterly with 25% vesting on June 6, 2025; 25% vesting on September 6, 2025; 25% vesting on December 6, 2025; and 25% vesting on March 6, 2026 |
Common Stock
|
20,000 |
| 2025-03-04 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.01 to $2.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-02-26 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-02-19 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.21 to $2.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-02-12 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-01-29 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.07 to $2.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-01-15 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-01-08 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.95 to $2.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2025-01-01 | COBB BRIAN J. |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
These shares are restricted and vest 25% annually until December 31, 2028 |
Common Stock
|
125,000 |
| 2024-12-18 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2024-12-05 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2024-12-03 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2024-11-21 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
Common Stock
|
10,000 |
| 2024-11-19 | Ludwig David Van |
Director, President of subsidiary |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction reflects the sale of shares made pursuant to a previously established 10b5-1 plan The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The original Form 4, filed on November 20, 2024 (the "Original Filing"), is being amended by this Form 4 amendment (the "Amendment") solely to correct an administrative error which underreported the amount of securities beneficially owned by the reporting person following a sale transaction that occurred on November 19, 2024 by less than 1,825 shares. As a result of this administrative error, all Form 4s filed by the reporting person after the Original Filing underreported the amount of securities beneficially owned by the reporting person by 1,825 shares. This Amendment corrects the amount of securities beneficially owned by the reporting person in the Original Filing by increasing the amount by 1,825 shares. |
Common Stock
|
10,000 |